Soc. Generale Knock-Out REGN/ DE000SJ0DZN2 /
| 23/01/2025 21:37:24 | Chg.-0.14 | Bid22:00:35 | Ask22:00:35 | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 6.43EUR | -2.13% | - Bid Size: - |
- Ask Size: - |
Regeneron Pharmaceut... | 1,365.1343 USD | 31/12/2078 | Put |
Newsfile Corp
23/01
REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportun...
Newsfile Corp
23/01
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Coun...
Newsfile Corp
23/01
Securities Class Action Allegations Cast Shadow Over Regeneron Pharmaceuticals (REGN)- Hagens Berman
Newsfile Corp
23/01
SHAREHOLDER ALERT: Berger Montague Reminds Regeneron Pharmaceuticals (NASDAQ: REGN) Investors of a C...
Newsfile Corp
22/01
REGENERON PHARMACEUTICALS SECURITIES FRAUD NOTICE: Berger Montague Informs Regeneron Pharmaceuticals...
Newsfile Corp
21/01
ROSEN, A LEADING LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Be...
Newsfile Corp
21/01
Faruqi & Faruqi Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit with...
Newsfile Corp
20/01
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secu...
Newsfile Corp
19/01
REGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Regeneron Pharmaceuticals, Inc...
Newsfile Corp
18/01
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Cou...
Newsfile Corp
18/01
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Phar...
Newsfile Corp
17/01
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to S...
Newsfile Corp
16/01
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmac...
Newsfile Corp
14/01
Regeneron Pharmaceuticals, Inc. (REGN) Securities Fraud: Contact Berger Montague To Discuss Your Rig...
Newsfile Corp
12/01
STOCKHOLDER ALERT: Pending Securities Fraud Lawsuit Against Regeneron Pharmaceuticals (REGN)
Newsfile Corp
12/01
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmac...
Newsfile Corp
10/01
REGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Regeneron Pharmaceuticals, Inc...
Newsfile Corp
10/01
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Phar...
GlobeNewswire
28/08/2024
Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference
GlobeNewswire
26/08/2024
Ordspono™ (odronextamab) Approved in the European Union for the Treatment of Relapsed/Refractory Fol...
GlobeNewswire
26/08/2024
Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadersh...
GlobeNewswire
21/08/2024
Regeneron Provides Update on Biologics License Application for Linvoseltamab
GlobeNewswire
15/08/2024
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...